245 related articles for article (PubMed ID: 33566300)
41. Circulating epithelial tumor cell analysis in CSF in patients with leptomeningeal metastases.
van Bussel MTJ; Pluim D; Milojkovic Kerklaan B; Bol M; Sikorska K; Linders DTC; van den Broek D; Beijnen JH; Schellens JHM; Brandsma D
Neurology; 2020 Feb; 94(5):e521-e528. PubMed ID: 31907288
[TBL] [Abstract][Full Text] [Related]
42. Remarkable response to dacomitinib in a patient with leptomeningeal carcinomatosis due to EGFR-mutant non-small cell lung cancer.
Mizusaki S; Otsubo K; Ninomiya T; Arimura H; Tsuchiya-Kawano Y; Inoue K
Thorac Cancer; 2021 Jan; 12(1):114-116. PubMed ID: 33112047
[TBL] [Abstract][Full Text] [Related]
43. Clinical outcomes of leptomeningeal metastasis in patients with non-small cell lung cancer in the modern chemotherapy era.
Park JH; Kim YJ; Lee JO; Lee KW; Kim JH; Bang SM; Chung JH; Kim JS; Lee JS
Lung Cancer; 2012 Jun; 76(3):387-92. PubMed ID: 22186628
[TBL] [Abstract][Full Text] [Related]
44. Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors for Non-Small-Cell Lung Cancer Patients with Leptomeningeal Carcinomatosis.
Liao BC; Lee JH; Lin CC; Chen YF; Chang CH; Ho CC; Shih JY; Yu CJ; Yang JC
J Thorac Oncol; 2015 Dec; 10(12):1754-61. PubMed ID: 26334749
[TBL] [Abstract][Full Text] [Related]
45. Leptomeningeal carcinomatosis in non-small-cell lung cancer patients: impact on survival and correlated prognostic factors.
Lee SJ; Lee JI; Nam DH; Ahn YC; Han JH; Sun JM; Ahn JS; Park K; Ahn MJ
J Thorac Oncol; 2013 Feb; 8(2):185-91. PubMed ID: 23328548
[TBL] [Abstract][Full Text] [Related]
46. [Different Gene Mutation Spectrum of the Paired CSF and Plasma Samples in Lung Adenocarcinoma with Leptomeningeal Metastases: the Liquid Biopsy Based on Circulating Tumor DNA].
Li H; Xie Y; Lin Y; Yu T; Yin Z
Zhongguo Fei Ai Za Zhi; 2020 Aug; 23(8):646-654. PubMed ID: 32838487
[TBL] [Abstract][Full Text] [Related]
47. High-efficiency EGFR genotyping using cell-free DNA in bronchial washing fluid.
Murata Y; Nakajima Y; Sato Y; Hizawa N; Yamakawa D; Matsubara D; Noguchi M; Minami Y
Jpn J Clin Oncol; 2024 Jun; 54(6):681-688. PubMed ID: 38476004
[TBL] [Abstract][Full Text] [Related]
48. Multiplex picoliter-droplet digital PCR for quantitative assessment of EGFR mutations in circulating cell-free DNA derived from advanced non-small cell lung cancer patients.
Yu Q; Huang F; Zhang M; Ji H; Wu S; Zhao Y; Zhang C; Wu J; Wang B; Pan B; Zhang X; Guo W
Mol Med Rep; 2017 Aug; 16(2):1157-1166. PubMed ID: 29067441
[TBL] [Abstract][Full Text] [Related]
49. Increasing discrepancy of MR imaging and CSF study in patients with leptomeningeal seeding from lung adenocarcinoma after targeted therapy using a tyrosine kinase inhibitor.
Seong M; Park S; Kim ST; Goo Park S; Kim Y; Cha J; Yeop Kim E; Kim HJ; Ahn MJ
Medicine (Baltimore); 2023 Oct; 102(40):e35387. PubMed ID: 37800766
[TBL] [Abstract][Full Text] [Related]
50. Efficacy of the irreversible ErbB family blocker afatinib in epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI)-pretreated non-small-cell lung cancer patients with brain metastases or leptomeningeal disease.
Hoffknecht P; Tufman A; Wehler T; Pelzer T; Wiewrodt R; Schütz M; Serke M; Stöhlmacher-Williams J; Märten A; Maria Huber R; Dickgreber NJ;
J Thorac Oncol; 2015 Jan; 10(1):156-63. PubMed ID: 25247337
[TBL] [Abstract][Full Text] [Related]
51. Picoliter-Droplet Digital Polymerase Chain Reaction-Based Analysis of Cell-Free Plasma DNA to Assess EGFR Mutations in Lung Adenocarcinoma That Confer Resistance to Tyrosine-Kinase Inhibitors.
Seki Y; Fujiwara Y; Kohno T; Takai E; Sunami K; Goto Y; Horinouchi H; Kanda S; Nokihara H; Watanabe S; Ichikawa H; Yamamoto N; Kuwano K; Ohe Y
Oncologist; 2016 Feb; 21(2):156-64. PubMed ID: 26768482
[TBL] [Abstract][Full Text] [Related]
52. Characterization of Liver Metastasis and Its Effect on Targeted Therapy in EGFR-mutant NSCLC: A Multicenter Study.
Jiang T; Cheng R; Zhang G; Su C; Zhao C; Li X; Zhang J; Wu F; Chen X; Gao G; Li W; Cai W; Zhou F; Zhao J; Xiong A; Ren S; Zhang G; Zhou C; Zhang J
Clin Lung Cancer; 2017 Nov; 18(6):631-639.e2. PubMed ID: 28549835
[TBL] [Abstract][Full Text] [Related]
53. Multiple combination therapy based on intrathecal pemetrexed in non-small cell lung cancer patients with refractory leptomeningeal metastasis.
Miao Q; Zheng X; Zhang L; Jiang K; Wu B; Lin G
Ann Palliat Med; 2020 Nov; 9(6):4233-4245. PubMed ID: 33302683
[TBL] [Abstract][Full Text] [Related]
54. HER2 exon 20 insertion mutations in lung adenocarcinoma with leptomeningeal metastasis: a case report and response to poziotinib.
Fan Y; Qin J; Han N; Lu H
Ann Palliat Med; 2022 Apr; 11(4):1582-1588. PubMed ID: 34118831
[TBL] [Abstract][Full Text] [Related]
55. Pulsatile Erlotinib in EGFR-Positive Non-Small-Cell Lung Cancer Patients With Leptomeningeal and Brain Metastases: Review of the Literature.
How J; Mann J; Laczniak AN; Baggstrom MQ
Clin Lung Cancer; 2017 Jul; 18(4):354-363. PubMed ID: 28245967
[TBL] [Abstract][Full Text] [Related]
56. Successful treatment of nonsmall cell lung cancer patients with leptomeningeal metastases using whole brain radiotherapy and tyrosine kinase inhibitors.
Sakaguchi M; Maebayashi T; Aizawa T; Ishibashi N; Saito T
J Cancer Res Ther; 2020; 16(4):930-932. PubMed ID: 32930144
[TBL] [Abstract][Full Text] [Related]
57. Plasma epidermal growth factor receptor mutation testing with a chip-based digital PCR system in patients with advanced non-small cell lung cancer.
Kasahara N; Kenmotsu H; Serizawa M; Umehara R; Ono A; Hisamatsu Y; Wakuda K; Omori S; Nakashima K; Taira T; Naito T; Murakami H; Koh Y; Mori K; Endo M; Nakajima T; Yamada M; Kusuhara M; Takahashi T
Lung Cancer; 2017 Apr; 106():138-144. PubMed ID: 28285688
[TBL] [Abstract][Full Text] [Related]
58. Sputum cell-free DNA: Valued surrogate sample for the detection of EGFR exon 20 p.T790M mutation in patients with advanced lung adenocarcinoma and acquired resistance to EGFR-TKIs.
Wang Z; Li X; Zhang L; Xu Y; Wang M; Liang L; Jiao P; Li Y; He S; Du J; He L; Tang M; Sun M; Yang L; Di J; Zhu G; Li L; Liu D
Cancer Med; 2021 May; 10(10):3323-3331. PubMed ID: 33932095
[TBL] [Abstract][Full Text] [Related]
59. Clinical outcome in patients with leptomeningeal metastasis from non-small cell lung cancer: Okayama Lung Cancer Study Group.
Umemura S; Tsubouchi K; Yoshioka H; Hotta K; Takigawa N; Fujiwara K; Horita N; Segawa Y; Hamada N; Takata I; Yamane H; Kamei H; Kiura K; Tanimoto M
Lung Cancer; 2012 Jul; 77(1):134-9. PubMed ID: 22487432
[TBL] [Abstract][Full Text] [Related]
60. [Clinical characteristics and their influences on the survival of leptomeningeal metastasis derived from lung adenocarcinoma harboring epithelial growth factor receptor mutation].
Jiang AF; Zhou SS; Zhou Q; Zhao J; Li XP; Zhou RR; Li B
Zhonghua Yi Xue Za Zhi; 2023 Sep; 103(34):2713-2719. PubMed ID: 37675543
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
